Deborah Fischer

Deborah Fischer holds the position of Researcher in Pharmacy, contributing to medical research with a focus on pharmacology, cancer biology, and endocrine disorders. Her work aligns with UN Sustainable Development Goals through advancements in healthcare innovation. She is affiliated with the Christabel Pankhurst Institute under the Advanced Materials in Medicine research platform.

• Department: Pharmacy
• Key Research Areas: Endometrial Cancer, Cancer Stem Cells, Prostaglandin Receptors, Mouse Model Development

Her research explores topics such as regulatory T cell modulation, fibroblast growth factor inhibitors for endometriosis, and metformin's role in cancer stem cell activity. Fischer has published extensively in journals like Biochemical Pharmacology and Pharmacology research & perspectives, with notable work on omega-3 fatty acids' immune effects and prostaglandin receptor functions in human reproduction. Her studies often utilize mouse models to bridge preclinical and translational research.

Fischer's research has garnered significant attention, including 52 social media shares and 40 Mendeley readers for her 2022 study on ceramide pathways. She has supervised 1 student project and collaborates with experts in pharmacology, oncology, and reproductive biology.